Mesoblast Ltd. Files ASX Announcement
Ticker: MEOBF · Form: 6-K · Filed: Jul 23, 2024 · CIK: 1345099
| Field | Detail |
|---|---|
| Company | Mesoblast LTD (MEOBF) |
| Form Type | 6-K |
| Filed Date | Jul 23, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, announcement
TL;DR
MESO filed an ASX announcement, check Exhibit 99.1 for details.
AI Summary
On July 22, 2024, Mesoblast Limited filed a new release announcement with the Australian Securities Exchange. This report is being furnished to the SEC as part of their ongoing reporting obligations. The filing does not contain specific financial figures or operational updates beyond the announcement itself.
Why It Matters
This filing indicates Mesoblast Limited is adhering to its reporting requirements by submitting an announcement made to the Australian Securities Exchange. Investors should review the attached announcement for specific details.
Risk Assessment
Risk Level: low — This filing is a routine submission of a press release and does not contain new material financial or operational information that would inherently increase risk.
Key Players & Entities
- Mesoblast Limited (company) — Registrant
- Silviu Itescu (person) — Chief Executive Officer and Executive Director
- Australian Securities Exchange (company) — Exchange where announcement was filed
- July 22, 2024 (date) — Date of announcement filing
FAQ
What is the primary purpose of this 6-K filing?
The primary purpose is to furnish a new release announcement filed by Mesoblast Limited with the Australian Securities Exchange on July 22, 2024, as an exhibit to the SEC filing.
What specific operational or financial information is detailed in this 6-K filing itself?
This 6-K filing itself does not detail specific operational or financial information; it primarily serves to attach the announcement made to the Australian Securities Exchange.
Who is identified as the Chief Executive Officer and Executive Director of Mesoblast Limited?
Silviu Itescu is identified as the Chief Executive Officer and Executive Director of Mesoblast Limited.
On what date was the announcement filed with the Australian Securities Exchange?
The announcement was filed with the Australian Securities Exchange on July 22, 2024.
Does Mesoblast Limited file annual reports under Form 20-F or Form 40-F?
Mesoblast Limited indicates that it files annual reports under Form 20-F.
Filing Stats: 358 words · 1 min read · ~1 pages · Grade level 13.2 · Accepted 2024-07-22 20:18:07
Filing Documents
- a2024-07x23clbppatientenro.htm (6-K) — 25KB
- exhibit991.htm (EX-99.1) — 10KB
- exhibit992.htm (EX-99.2) — 4KB
- exhibit993.htm (EX-99.3) — 15KB
- exhibit994.htm (EX-99.4) — 11KB
- exhibit991001.jpg (GRAPHIC) — 280KB
- exhibit991002.jpg (GRAPHIC) — 284KB
- exhibit992001.jpg (GRAPHIC) — 123KB
- exhibit992002.jpg (GRAPHIC) — 126KB
- exhibit993001.jpg (GRAPHIC) — 75KB
- exhibit993002.jpg (GRAPHIC) — 58KB
- exhibit993003.jpg (GRAPHIC) — 56KB
- exhibit993004.jpg (GRAPHIC) — 119KB
- exhibit993005.jpg (GRAPHIC) — 94KB
- exhibit993006.jpg (GRAPHIC) — 53KB
- exhibit994001.jpg (GRAPHIC) — 75KB
- exhibit994002.jpg (GRAPHIC) — 52KB
- exhibit994003.jpg (GRAPHIC) — 71KB
- exhibit994004.jpg (GRAPHIC) — 114KB
- 0001345099-24-000057.txt ( ) — 2241KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized. Mesoblast Limited s Niva Sivakumar Niva Sivakumar Company Secretary Dated July 23, 2024 INDEX TO EXHIBITS Item 99.1 Press release of Mesoblast Ltd, dated July 22, 2024. 99.2 Appendix 3Y of Mesoblast Ltd, dated July 12, 2024. 99.3 Appendix 3G of Mesoblast Ltd, dated July 12, 2024. 99.4 Appendix 3H of Mesoblast Ltd, dated July 12, 2024.